Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infection/inflammation and hemostasis.

Jean-Louis Vincent1

  • 1Department of Intensive Care, Erasme University Hospital, Route de Lennik 808, 1070 Brussels, Belgium. jlvincen@ulb.ac.be

Current Hematology Reports
|August 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery.

The Journal of thoracic and cardiovascular surgery·2015
Same author

A new device for the prevention of pulmonary embolism in critically ill patients: Results of the European Angel Catheter Registry.

The journal of trauma and acute care surgery·2015
Same author

A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
Same author

Near infrared spectroscopy (NIRS) to assess the effects of local ischemic preconditioning in the muscle of healthy volunteers and critically ill patients.

Microvascular research·2015
Same author

Should red cell transfusion be individualized? Yes.

Intensive care medicine·2015
Same author

Assessing Cellular Responses in Sepsis.

EBioMedicine·2015
Same journal

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006
Same journal

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006
Same journal

Volume-reduced platelet concentrates.

Current hematology reports·2006
Same journal

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006
Same journal

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006
Same journal

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006
See all related articles

Severe sepsis involves a dangerous cycle where inflammation worsens coagulation, leading to organ damage. Understanding this link aids in developing new treatments like recombinant activated protein C for better patient outcomes.

Area of Science:

  • Biomedical Science
  • Pathophysiology
  • Pharmacology

Background:

  • Inflammation and coagulation are intricately linked in a bidirectional manner.
  • This interaction can create a detrimental cycle, exacerbating vascular injury and organ dysfunction.
  • Severe sepsis is a critical condition often resulting from this complex interplay.

Purpose of the Study:

  • To explore the mechanisms underlying the interaction between infection, inflammation, and coagulation.
  • To identify potential therapeutic targets for severe sepsis.
  • To highlight advancements in treatment strategies for severe sepsis.

Main Methods:

  • Review of existing literature on inflammation and coagulation.
  • Analysis of the pathophysiology of severe sepsis.

Related Experiment Videos

  • Evaluation of novel therapeutic agents.

    • Main Results:

    • The association between inflammation and coagulation is a two-way process.
    • Key hemostatic proteins can propagate inflammation, worsening the condition.
    • Recombinant activated protein C has demonstrated improved outcomes in severe sepsis patients.

    Conclusions:

    • Understanding the interplay between infection, inflammation, and coagulation is crucial for treating severe sepsis.
    • Recombinant activated protein C represents a promising therapeutic advancement.
    • Further research into these mechanisms may yield more effective treatments for severe sepsis.